Special PET Scan Before Immunotherapy for Mesothelioma
Part of Cancer, Lungs & breathing clinical trials.
This trial uses a special PET scan (called Ga-68 FAPI) to see if it can help doctors better plan or monitor immunotherapy for people with pleural mesothelioma. It may help doctors predict how well the treatment will work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of pleural mesothelioma (a cancer of the lung lining).
- You are scheduled to receive immunotherapy (drugs like PD-L1 or CTLA-4 inhibitors) as your first or second treatment.
- You must be physically able to walk and take care of yourself (ECOG score 0 or 1).
- You must agree to participate in the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a newer type of PET scan (FAPI PET) can better diagnose pleural mesothelioma than a standard FDG PET scan. If you have a suspicious spot in your lung lining and need a biopsy, this study may help improve how we find and track this cancer.
This trial uses a special PET scan (68Ga-FAPI PET/CT) to see how well cancer in the abdomen (peritoneal metastases) is responding to chemotherapy. It may help doctors decide if the treatment is working.
This trial uses a special PET/CT scan (called 18F-grazy-02) to look at a protein in your body that may show how well your immune system is fighting the cancer. It is for people with non-small cell lung cancer or melanoma to help their doctors monitor the effects of immunotherapy.
This study uses a special type of PET scan to look at specific cells in non-small cell lung cancer tumors that might help doctors understand how well immunotherapy treatments are working. If you are about to start immunotherapy for advanced lung cancer, you may be able to join.
This trial tests a special PET scan (68Ga-grazytracer) to see if it can predict early whether immunotherapy is working in people with lung cancer that can be surgically removed. If successful, this scan could help doctors tailor treatment sooner.
This trial tests a special PET scan that tracks immune activity to see if it can help monitor how well immunotherapy is working in people with various cancers. It is for patients about to start immunotherapy for the first time.
Hear when a new Mesotheliomas Pleural trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.